134
Participants
Start Date
August 31, 2011
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
SCD
The selective cytopheretic device (SCD) is comprised of tubing, connectors and a hemofilter cartridge. The device is connected in series to a commercially available Continuous Renal Replacement Therapy (CRRT) device. Blood from the CRRT circuit is diverted after the CRRT hemofilter through to the extra capillary space (ECS) of the SCD. Blood circulates through this space and is returned to the patient via the venous return line of the CRRT circuit. Regional citrate anticoagulation is used for the entire CRRT and SCD blood circuits.
Mount Sinai School of Medicine, New York
Albany Medical College, Albany
University of Maryland, Baltimore
INOVA Health Care Services, Falls Church
Virginia Commonwealth University, Richmond
Medical University Of South Carolina, Charleston
University of Florida, Jacksonville
University of Florida, Gainesville
University of Alabama Birmingham, Birmingham
Memorial Hospital, Chattanooga
Erlanger Hospital, Chattanooga
University of Mississippi, Jackson
Cleveland Clinic, Cleveland
Henry Ford Hospital, Detroit
University of Iowa, Iowa City
University of Wisconsin, Madison
Sanford Health, Fargo
Northwestern University, Chicago
Washington University, St Louis
Dallas VA Medical Center, Dallas
University of Texas, Houston
UCLA, Los Angeles
University of California, San Diego, San Diego
Massachusetts General Hospital, Boston
Beth Isreal Deaconess Medical Center, Boston
Baystate Medical Center, Springfield
Lead Sponsor
SeaStar Medical
INDUSTRY